Korro Bio (KRRO) EBIAT (2019 - 2025)
Historic EBIAT for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$18.1 million.
- Korro Bio's EBIAT rose 1399.11% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.4 million, marking a year-over-year decrease of 69.36%. This contributed to the annual value of -$83.6 million for FY2024, which is 296.78% down from last year.
- As of Q3 2025, Korro Bio's EBIAT stood at -$18.1 million, which was up 1399.11% from -$25.8 million recorded in Q2 2025.
- Korro Bio's 5-year EBIAT high stood at $6.2 million for Q4 2022, and its period low was -$25.8 million during Q2 2025.
- Over the past 5 years, Korro Bio's median EBIAT value was -$21.0 million (recorded in 2024), while the average stood at -$19.7 million.
- Its EBIAT has fluctuated over the past 5 years, first soared by 12877.21% in 2022, then crashed by 51102.49% in 2023.
- Over the past 5 years, Korro Bio's EBIAT (Quarter) stood at -$21.5 million in 2021, then skyrocketed by 128.77% to $6.2 million in 2022, then tumbled by 511.02% to -$25.4 million in 2023, then increased by 16.62% to -$21.2 million in 2024, then grew by 14.8% to -$18.1 million in 2025.
- Its EBIAT was -$18.1 million in Q3 2025, compared to -$25.8 million in Q2 2025 and -$23.4 million in Q1 2025.